Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 31 for “"Covalent Inhibition"”.
-
Towards covalent inhibition of phosphoglucomutase in Aspergillus fumigatus
… that recombinantly expressed A<i>f</i>PGM can be covalently inhibited via a cysteine residue (C353) not conserved in the human orthologue. Two mechanistically dissimilar probes were utilised to interrogate the enzyme and its mutein, showing that inhibition is elicited exclusively via cysteine …
-
Computational Investigation of Pathogenic Enzymes and their Covalent Inhibition
… model calculations were employed to investigate inhibition reactions and compare our mechanistic findings with experimental results. The QM model approach is also applied to RNA targeting covalent ligands to discern the experimentally observed selectivity for certain nucleobases. This work …
-
Synthetic organic approaches for the covalent inhibition of protein-protein interactions
… electrophilic warhead which can form reversible covalent interactions with N- or O-centred Lewis basic/nucleophilic amino acid residues at a protein binding interface
-
DEVELOPMENT OF OPEN LACTAM AND CAPTOPRIL ANALOGUES FOR THE COVALENT INHIBITION OF METALLO-β-LACTAMASES
… OF OPEN LACTAM AND CAPTOPRIL ANALOGUES FOR THE COVALENT INHIBITION OF METALLO-β-LACTAMASES ByMARIE-JOSIANE OHOUEU University of New Hampshire, May 2021 The synthesis of a series of compounds designed to act as inhibitors of metallo-β-lactamase enzymes (MBLs), a sub-class of β-lactamases found in …
-
Waging Warheads: Investigation of Electrophilic Warheads for Targeted Covalent Inhibition of Transglutaminase 2 and Beyond
Covalent inhibition has re-emerged as a powerful therapeutic strategy, with attenuated electrophilic warheads enabling selective and sustained target engagement. Despite their central role, warheads are often treated primarily as elements for tuning electrophilicity, and their broader structural …
-
Covalent Inhibition of Enzyme Sortase A as a New Pathway Against Bacterial Resistance of Staphylococcus Aureus
… of S. aureus, promotes bacterial virulence by covalently attaching proteins such as pilin to the bacterial surface, enabling bacterial adhesion to mammalian cells. Inhibitory studies of this enzyme have gained prominent interest as a new pathway for drug development since blocking this enzyme's …
-
A Chemical Biology Exploration to Modulate and Investigate Protein Activity Using Covalent Inhibition and Inducing Post Translational Modification
… that has been regaining interest is targeted covalent inhibition (TCI). This have evolved from what was originally regarded as a liability to an indispensable component in the field of chemical biology and medicinal chemistry. Despite the recent advances involving TCIs such as the development …
-
Investigating the activity of alternative warheads for targeted covalent inhibition of the Inhibitor Vertebrate Lysozyme protein from Pseudomonas aeruginosa
… bacterial cell wall.2 A class of drugs targeted covalent inhibitors (TCIs) were chosen as the weapon for fighting Ivyp1. TCIs are molecules that form a covalent bond between a nucleophilic atom on the target protein and an electrophilic atom on the TCI itself.3 This irreversible binding prevents …
-
Development of lysine-targeted irreversible inhibitors of PI3K?
Targeted covalent inhibition of poorly conserved cysteine residues for kinase inhibition has increased in popularity over recent years. Whilst these inhibitors are often highly successful, studies have shown that only ~40% of human kinases are amenable to this approach. Furthermore, cysteine …
-
Atropisomeric fragments in drug discovery and probe compound development
… to synthesise molecular probes for KRas G12C covalent inhibition, following the discovery of sotorasib (AMG 510). Probe 120 was synthesised, assessed in biological studies, and optimised to lead to probe 150, active against KRas G12C in the low micromolar range as a racemate. </p>
-
Mechanistic and inhibition studies on isocitrate dehydrogenase 1
… providing the mechanistic basis for mutant IDH inhibition and the opportunities for improved therapies through metal ion interference. Comparative studies on clinically relevant mIDH inhibitors showed that the mIDH1 inhibitors bind to wt IDH1 and R132H IDH1 with similar binding affinities …
-
Covalent probes for functional and structural characterization of glycoside hydrolases
… targeting a variety of GHs by irreversible covalent inhibition. These probes, developed on oligosaccharide scaffolds, feature either an N-bromoacetylglycosylamine electrophilic warhead or 2', 4' dinitrophenyl 2-deoxy-2-fluoro substitutions, facilitating irreversible inhibition of the target …
-
Targeted protein degradation as a new approach to drug discovery
… offers several advantages over small-molecule inhibition alone as efficacy can be driven from low drug concentrations, extended duration of action can be achieved, and scaffolding functions of the target protein can be removed.In this thesis, the application of Protac technology towards a …
-
Synthesis of a Potential Selective Covalent Inhibitor of Isocitrate Lyase from Mycobacterium tuberculosis
… nitro group acting as a masked electrophile for covalent modification of the enzyme at the Cys191 residue. This compound, however, reacts similarly with human succinate dehydrogenase, making it toxic and therefore inadequate for treating the infection. This work aimed to synthesize a more …
-
Synthesis and development of novel small molecule inhibitors of nucleophilic hydrolases
… potential to inhibit nucleophilic enzymes by covalent reaction with nucleophilic active site residues, owing to the presence of their electrophilic boron or γ-lactam carbonyl groups, respectively.</p> <p><strong>Chapter 2</strong> describes the synthesis of a set of C6-functionalised …
-
Investigating Whether Txnrd2 Is a Therapeutic Target Against Triple Negative Breast Cancer Using African American-Derived Models
… of targeting TXNRD2 using a new class of non-covalent TXNRD inhibitors, TXNRD(i)s, which bind an allosteric site rather than relying on traditional covalent inhibition. To distinguish the activity of TXNRD2 from its close homologue TXNRD1, we developed a dual-labeling live-cell microscopy …
-
TARGET VALIDATION OF UK-101 AND FUNCTIONAL STUDIES OF β1i
… effect was directly mediated by its irreversible inhibition of β1i. Since off-target effects are major roadblocks for the development of new and effective pharmaceuticals, target validation studies in this system would assist in the further progression of β1i inhibitors towards preclinical trials. …
-
Mutate & conjugate: a method for rapid in-cell validation of epigenetic targets
… over the “knockdown”. In this approach, reactive covalent fragments have been combined with a cysteine mutant of the target protein. It was hypothesised that covalent inhibition would circumvent the need to optimise ligand affinity, accelerating probe development, while also offering increased …
-
Structural basis of ubiquitin recognition and rational design of novel covalent inhibitors targeting Cdu1 from \(Chlamydia\) \(Trachomatis\)
… represent the first active-site directed covalent reversible inhibitors for Cdu1. High-resolution crystal structures of Cdu1 in complex with the covalently bound cyano-pyrimidines as well as with its substrate ubiquitin have been elucidated. The structural data of this thesis, combined …
-
THE DEVELOPMENT OF NOVEL NON-PEPTIDE PROTEASOME INHIBITORS FOR THE TREATMENT OF SOLID TUMORS
… that compounds with non-peptidic structures, non-covalent and reversible modes of action, and unique selectivity profiles against the proteasome’s distinct catalytic subunits could have superior pharmacodynamic and pharmacokinetic properties and may bear improved activity against solid tumors …
Page 1 of 2